ライフサイエンスコーパス: cystoscopy

1 moval at 6 weeks after transplantation (with cystoscopy).

2 ns in comparison to conventional white light cystoscopy.

3 tive results, and are unlikely to substitute cystoscopy.

4 nce that any marker can replace surveillance cystoscopy.

5 , 72% (142 of 197), and 99% (634 of 641) for cystoscopy.

6 including implementing robotics and flexible cystoscopy.

7 ntinues to rely on direct visualization with cystoscopy.

8 short-term recurrence rates than white light cystoscopy.

9 lysis of NMP22 protein and cytology prior to cystoscopy.

10 have been made in the field of fluorescence cystoscopy.

11 hypericin) and their application to flexible cystoscopy.

12 ved sensitive and specific enough to replace cystoscopy.

13 this technique can be used for office-based cystoscopy.

14 The diagnosis is made by cystoscopy.

15 ssibly play a complementary role to standard cystoscopy.

16 ew developments in the field of fluorescence cystoscopy.

17 died to improve the accuracy of fluorescence cystoscopy.

18 plasms underwent CT virtual and conventional cystoscopy.

19 "mixed flora" in an elderly male following a cystoscopy.

20 aturia and abnormal findings at conventional cystoscopy.

21 At conventional cystoscopy, 29 masses appeared to arise from the bladder

22 At virtual cystoscopy, 30 masses arose from the bladder (one prosta

23 Use of cystoscopy (8.1%) and sigmoidoscopy or proctoscopy (8.6%

24 ot significantly increase the sensitivity of cystoscopy (94.2%; 95% CI, 87.7%-97.8%; P = .08).

25 Based on the ultrasound, CT, MRI and cystoscopy, a local recurrence of cancer was presumed in

26 Cystoscopy alone identified 91.3% of the cancers (94/103

27 to the invasiveness and expense of frequent cystoscopies and the lack of sensitivity of urinary cyto

28 Cystoscopy and biopsy showed a 4-cm mass at the right ur

29 evidence of disease at their post-treatment cystoscopy and biopsy.

30 ative limitations of the current standard of cystoscopy and cytology, there has been burgeoning activ

31 3 of the malignancies missed during initial cystoscopy and did not significantly increase the sensit

32 nicians should consider urology referral for cystoscopy and imaging in adults with microscopically co

33 ts who had bladder abnormalities noted using cystoscopy and in 1 patient with an increased prostate-s

34 The mainstay of diagnosis remains cystoscopy and transurethral resection, with enhanced op

35 its availability in both flexible and rigid cystoscopy and ureteroscopy and its potential for detect

36 ctively compared with results of urinalysis, cystoscopy and/or ureteroscopy, and/or surgery.

37 , as many 'routine cases' when examined with cystoscopy are found to be associated with complications

38 theter was removed in a joint manner without cystoscopy at 2 weeks.

39 ients with nonglomerular hematuria (82%) had cystoscopy at the NIH.

40 opy were comparable to those at conventional cystoscopy but were obtained without the associated risk

41 Cystoscopy continues to be routinely used, as many 'rout

42 rs may be a useful alternative or adjunct to cystoscopy for diagnosis of bladder cancer.

43 Forty-two of the 60 patients (70%) who had cystoscopy had macroscopic changes consistent with cyclo

44 agents to the armamentarium of fluorescence cystoscopy has great potential with promising results in

45 usually used in the clinic as an adjunct to cystoscopy; however, it suffers from low sensitivity.

46 Stones were removed by cystoscopy in 11 (55%) patients.

47 number of articles have examined the use of cystoscopy in all cases of complicated pelvic surgery an

48 raphy in patients with hematuria may obviate cystoscopy in selected patients.

49 ase II and III trials outperform white light cystoscopy in terms of cancer detection and recurrence-f

50 recent literature on the use of fluorescence cystoscopy in the diagnosis and management of bladder ca

51 cers that were not visualized during initial cystoscopy, including 7 that were high-grade.

52 gists blinded to the results of conventional cystoscopy independently reviewed the transverse and vir

53 CT virtual cystoscopy is a promising technique for use in bladder t

54 Cystoscopy is currently the "gold standard," but it is i

55 CT urography combined with cystoscopy is emerging as the diagnostic imaging pathway

56 Cystoscopy is standard but can fail to detect some bladd

57 However, at that time, a cystoscopy of his primary tumor and a transurethral rese

58 ses of extravasation were preceded by recent cystoscopy or placement of a Foley catheter; one case wa

59 ither early stent removal at 5 days (without cystoscopy) or late removal at 6 weeks after transplanta

60 mor growth from imaging studies, findings at cystoscopy, or histologic interpretation of biopsies.

61 the routine use of barium enema examination, cystoscopy, or proctoscopy.

62 de replacement or reduction in the number of cystoscopies performed in the surveillance of bladder ca

63 Morbidity is substantial, with frequent cystoscopy, recurrence, resections, and possible cystect

64 Cystoscopy remains the gold standard for diagnosis of bl

65 Cystoscopy remains the mainstay in the detection and sur

66 Cystoscopy remains the mainstay in the detection and sur

67 Cystoscopy remains the mainstay in the detection and sur

68 Cystoscopy reports were classified as positive if a lesi

69 er tumors can be detected using fluorescence cystoscopy resulting in improved cancer detection and lo

70 eated for bladder cancer and having negative cystoscopy results.

71 Fluorescence cystoscopy should be considered as an adjunctive tool fo

72 eliminary results with flexible fluorescence cystoscopy suggest that this technique can be used for o

73 o improve the utility of urinary markers and cystoscopy through fluorescence endoscopy.

74 used in conjunction with urine cytology and cystoscopy to improve clinical diagnosis of bladder canc

75 Virtual cystoscopy was performed in 13 patients with hematuria a

76 Cystoscopy was repeated 6 weeks after therapy.

77 Results at virtual cystoscopy were comparable to those at conventional cyst

78 of 40 bladder lesions proved at conventional cystoscopy were detected with a combination of transvers

79 ce characteristics for both CT urography and cystoscopy were determined by using pathologic findings

80 ndard for the diagnosis of bladder cancer is cystoscopy, which is invasive and painful for patients.

81 Fluorescence cystoscopy with 5-aminolevulinic acid and hexaminolevuli

82 Efficacy was evaluated by cystoscopy with biopsy, cytology, and computed tomograph

83 nosis of bladder cancer recurrence, based on cystoscopy with biopsy, was accepted as the reference st

84 The combination of cystoscopy with the NMP22 assay detected 99.0% of the ma

85 cent advances have been made in fluorescence cystoscopy with the use of newer fluorescence agents (he

86 tory of urothelial cancer, who had undergone cystoscopy within 6 months of the CT urogram, were inclu